InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by McMinn Rachel, Chief Executive Officer. Officer active across 2 companies, notably Neurogene Inc.. In total, 7 reports have been logged. Breakdown: 1 buy · 3 sells. Total volume traded: €990k. Activity tracked since 22 November 2024. The latest transaction was filed on 26 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Rachel McMinn is the Chief Executive Officer of Neurogene Inc. She leads the company, focusing on growth strategy and innovation. Her leadership is crucial for achieving organizational goals and strengthening the market position of the firm.